Risk of delayed bleeding after colorectal endoscopic submucosal dissection: the Limoges bleeding score.


Journal

Endoscopy
ISSN: 1438-8812
Titre abrégé: Endoscopy
Pays: Germany
ID NLM: 0215166

Informations de publication

Date de publication:
10 Oct 2023
Historique:
medline: 11 10 2023
pubmed: 11 10 2023
entrez: 10 10 2023
Statut: aheadofprint

Résumé

Clinically significant delayed bleeding (CSDB) is a frequent, and sometimes severe, adverse event after colorectal endoscopic submucosal dissection (ESD). We evaluated risk factors of CSDB after colorectal ESD. We analyzed a prospective registry of 940 colorectal ESDs performed from 2013 to 2022. The incidence of bleeding was evaluated up to 30 days. Risk factors for delayed bleeding were evaluated by multivariate logistic regression. A Korean scoring model was tested, and a new risk-scoring model was developed and internally validated. CSDB occurred in 75 patients (7.98%). The Korean score performed poorly in our cohort, with an ROC of 0.567. In the multivariate analysis, risk factors were age ≥ 75 years (OR, 1.60; 95% CI, 0.95,2.7; 1 point), use of antithrombotics (OR, 1.72; 95% CI, 1.01, 2.94; 1 point), rectal location (OR, 1.51; 95% CI, 0.92, 2.48; 1 point), size > 50mm (OR, 3.63; 95% CI, 2.02, 7.14; 3 points), and ASA score of III or IV (OR, 2.26; 95% CI, 1.32, 3.92; 2 points). The model showed a fair calibration and good discrimination, with an ROC curve of 0.751 (95% CI, 0.690-0.812). The score was used to define two groups of patients, those with low-medium (0 to 4 points) and high (5 to 8 points) risks of CSDB (respective bleeding rates 4.1% and 17.5%). A score based on five simple and meaningful variables is predictive of CSDB.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Clinically significant delayed bleeding (CSDB) is a frequent, and sometimes severe, adverse event after colorectal endoscopic submucosal dissection (ESD). We evaluated risk factors of CSDB after colorectal ESD.
METHODS METHODS
We analyzed a prospective registry of 940 colorectal ESDs performed from 2013 to 2022. The incidence of bleeding was evaluated up to 30 days. Risk factors for delayed bleeding were evaluated by multivariate logistic regression. A Korean scoring model was tested, and a new risk-scoring model was developed and internally validated.
RESULTS RESULTS
CSDB occurred in 75 patients (7.98%). The Korean score performed poorly in our cohort, with an ROC of 0.567. In the multivariate analysis, risk factors were age ≥ 75 years (OR, 1.60; 95% CI, 0.95,2.7; 1 point), use of antithrombotics (OR, 1.72; 95% CI, 1.01, 2.94; 1 point), rectal location (OR, 1.51; 95% CI, 0.92, 2.48; 1 point), size > 50mm (OR, 3.63; 95% CI, 2.02, 7.14; 3 points), and ASA score of III or IV (OR, 2.26; 95% CI, 1.32, 3.92; 2 points). The model showed a fair calibration and good discrimination, with an ROC curve of 0.751 (95% CI, 0.690-0.812). The score was used to define two groups of patients, those with low-medium (0 to 4 points) and high (5 to 8 points) risks of CSDB (respective bleeding rates 4.1% and 17.5%).
CONCLUSION CONCLUSIONS
A score based on five simple and meaningful variables is predictive of CSDB.

Identifiants

pubmed: 37816392
doi: 10.1055/a-2189-0807
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare that they have no conflict of interest.

Auteurs

Jérémie Albouys (J)

hepato-gastro-entérologie, Hopital Dupuytren, Limoges, France.

Sheyla Montori Pina (S)

Gastrointestinal Endoscopy Research Unit, Navarrobiomed, Pamplona, Spain.
Gastrointestinal Endoscopy Research Unit, Hospital Universitario de Navarra (HUN), Universidad Pública de Navarra (UPNA), IdiSNA, Pamplona, Spain.
Gastrointestinal Endoscopy Research Unit, IdiSNA, Pamplona, Spain.

Safia Boukechiche (S)

Hepatogastroenterology, Dupuytren Hospital, Limoges, France.

Eduardo Albéniz (E)

Gastroenterology. Endoscopy Unit., Hospital Universitario de Navarra (HUN), Pamplona, Spain.
Navarrabiomed; Universidad Pública de Navarra (UPNA); IdiSNA, Pamplona, Spain.

Guillame Vidal (G)

ISIT (Image Sciences for Innovations Techniques), UMR Université d'Auvergne/CNRS 6284, CLERMONT-FERRAND, France.

Romain Legros (R)

service d'hépato-gastro-entérologie, CHU Dupuytren, Limoges, France.

Martin Dahan (M)

service de gastroenterologie, Centre Hospitalier Universitaire de Limoges, Limoges, France.

Hugo Lepetit (H)

service d\'hépato-gastro-entérologie, CHU Dupuytren Limoges, Limoges, France.

Mathieu Pioche (M)

Endoscopy Unit, Digestive Disease Department, Hôpital Edouard Herriot, Lyon, France.

Marion Schaefer (M)

Hepato-gastroenterology, Centre Hospitalier Universitaire de Nancy, Vandoeuvre les Nancy, France.

Sophie Geyl (S)

service d'hépato-gastro-entérologie, CHU Dupuytren, Limoges, France.

Paul Carrier (P)

Hepato-gastro-entérologie, Centre Hospitalier Universitaire de Limoges, Limoges, France.

Veronique Loustaud-Ratti (V)

service d'hépato-gastro-entérologie, CHRU Dupuytren, Limoges, France.

Clémentine Brule (C)

Service d'hépato-gastro-entérologie, Centre Hospitalier Universitaire de Limoges, Limoges, France.

Rebecca Rodrigues (R)

Hepatogastro enterologie, CHU Limoges, Limoges, France.

Monica Enguita German (M)

Methodology Unit, Universidad de Navarra, Pamplona, Spain.

Jeremie Jacques (J)

service d'hépato-gastro-entérologie, CHU Dupuytren Limoges, Limoges, France.

Classifications MeSH